Malignant hyperthermia: a potential crisis in the postanesthesia care unit.
This article pertains to malignant hyperthermia (MH). The disease and its physiologic aspects are described, and a general overall view of what takes place at the cellular level during an MH crisis is presented. Also described is the drug of choice, dantrolene sodium, and its functioning during an MH crisis. The care of an MH patient in the PACU is presented, correlating all the above mentioned aspects of MH.